According to a new report published by Introspective Market Research, titled, “Vitamin B3 Market by Type, Form, and Application,” The Global Vitamin B3 Market Size Was Valued at USD 0.3829 Billion in 2024 and is Projected to Reach USD 0.5120 Billion by 2035, Growing at a CAGR of 2.65% From 2025–2035.
The Vitamin B3 market comprises an essential water-soluble vitamin, chemically known as nicotinic acid and nicotinamide (niacinamide), which is a critical component of human and animal nutrition. As a precursor to the coenzymes NAD and NADP, it plays a fundamental role in cellular energy metabolism, DNA repair, and nervous system function. The advantages of vitamin B3 supplementation or fortification over relying solely on dietary sources include ensuring a consistent, measurable intake to prevent deficiency diseases like pellagra, and its proven use in specific therapeutic applications, such as managing certain dyslipidemias (high cholesterol).
The primary growth driver for the vitamin B3 market is the sustained and growing global demand for high-quality animal protein, which drives the expansion and intensification of the animal feed industry. Niacin (primarily in the form of niacinamide) is an essential, non-negotiable vitamin additive in compound feed for poultry, swine, and increasingly, aquaculture. It is critical for proper growth, feed conversion efficiency, and overall health in these fast-growing production animals. As the global population and per capita income rise, especially in developing economies, consumption of meat, poultry, and fish increases. This directly translates into higher volumes of animal feed production, creating consistent, volume-driven demand for vitamin B3 as a core micronutrient, making the animal feed segment the stable foundation of the market.
A significant market opportunity lies in the expansion and premiumization of niacinamide (nicotinamide) applications within the booming cosmetics and skincare industry, alongside innovations in delivery forms for human nutrition. Niacinamide has transitioned from a niche ingredient to a mainstream powerhouse in skincare, valued for its multi-functional benefits like improving skin barrier function, reducing redness, and minimizing the appearance of pores and fine lines. This creates a high-value, rapidly growing application segment. Simultaneously, in human nutrition, there is an opportunity to develop novel, highly bioavailable, and stable delivery forms (e.g., microencapsulated powders, stable liquid formulations) for inclusion in next-generation functional beverages, gummies, and fortified foods, catering to the growing consumer focus on preventive health and targeted wellness.
Vitamin B3 Market, Segmentation
The Vitamin B3 Market is segmented on the basis of Type, Form, and Application.
Application
The Application segment is further classified into Animal Feed, Human Nutrition & Dietary Supplements, Pharmaceuticals, and Cosmetics & Personal Care. Among these, the Animal Feed sub-segment accounted for the highest market share in 2024. The animal feed application dominates due to the massive, consistent volume of niacinamide required by the global livestock and poultry industries. It is a standard, non-discretionary ingredient in premixes added to billions of tons of feed produced annually worldwide. The scale of modern meat and aquaculture production, driven by population growth and dietary shifts, ensures this segment remains the largest and most stable volume driver for vitamin B3, anchoring the entire market.
Type
The Type segment is further classified into Niacin (Nicotinic Acid) and Niacinamide (Nicotinamide). Among these, the Niacinamide (Nicotinamide) sub-segment accounted for the highest market share in 2024. Niacinamide dominates because it is the preferred form for the two largest application segments. In animal feed, it does not cause the "niacin flush" associated with nicotinic acid and is thus universally used. In the fast-growing cosmetics industry, niacinamide is the exclusive form utilized for its topical skin benefits. Its versatility, stability, and suitability for both internal (feed, supplements) and external (cosmetics) applications make it the more commercially prevalent and higher-growth type within the market.
Some of The Leading/Active Market Players Are-
• Lonza Group Ltd. (Switzerland)
• Jubilant Life Sciences Ltd. (India)
• Vertellus Holdings LLC (US)
• Vanetta (China)
• DSM-Firmenich (Netherlands/Switzerland)
• Bactolac Pharmaceutical, Inc. (US)
• Foodchem International Corporation (China)
• Merck KGaA (Germany)
• BASF SE (Germany)
• "and other active players."
Key Industry Developments
In March 2024, DSM-Firmenich expanded its production capacity for high-purity niacinamide at its Swiss facility. This investment specifically targets the growing demand from the premium cosmetics and human nutrition sectors, where stringent quality and purity standards are required, highlighting the strategic focus on high-value applications beyond traditional animal feed.
In January 2024, a major global animal nutrition company launched a new line of vitamin premixes featuring enhanced-stability niacinamide for aquafeed. The formulation is designed to withstand the high-heat, high-moisture conditions of aquaculture feed processing, ensuring optimal vitamin delivery to farmed fish and shrimp, addressing a key technical challenge in a rapidly growing segment of the feed industry.
Key Findings of the Study
• The Animal Feed application and Niacinamide product type are the dominant market segments.
• The Asia-Pacific region is the largest market, driven by its massive animal feed production and growing personal care industry.
• The key growth driver is the rising global demand for animal protein and subsequent feed production.
• Major trends include the premiumization of niacinamide in cosmetics and innovation in stable delivery forms for human nutrition.
